TBC1D16 and MAP1LC3A

  • Number of citations of the paper that reports this interaction (PMID 22354992)
  • 16
  • Data Source:
  • BioGRID (affinity chromatography technology, pull down)

TBC1D16

MAP1LC3A

Gene Name TBC1 domain family, member 16 microtubule-associated protein 1 light chain 3 alpha
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 15 interactors: GABARAPL1 KRT40 KRTAP10-5 KRTAP10-8 KRTAP10-9 KRTAP3-2 KRTAP4-12 KRTAP5-9 MAP1LC3A NOTCH2NL PSMA3 RGS17 RGS20 TNS2 TRAF1 40 interactors: AKAP13 APP ATG101 ATG13 ATG3 ATG4B ATG7 BNIP3L DVL2 EPHA7 FAM134C FUNDC1 KIF15 KXD1 MAP1A MAP1S NBR1 OPTN PIAS4 PRPF40A RABGAP1 RABGAP1L RDH12 RTKN SQSTM1 SRPK1 TBC1D1 TBC1D10A TBC1D10B TBC1D16 TBC1D17 TBC1D2 TBC1D25 TBC1D2B TBC1D5 TBC1D7 TBC1D9 TBC1D9B TNIP1 TUBA4A
Entrez ID 125058 84557
HPRD ID 10261 03144
Ensembl ID ENSG00000167291 ENSG00000101460
Uniprot IDs B9A6L7 I3L1E0 I3L4U2 Q8N3Z4 Q8TBP0 Q96DH7 Q9H492
PDB IDs 3ECI
Enriched GO Terms of Interacting Partners?
Tagcloud ?
acquiring  adenocarcinoma  autophagy  became  came  constitutive  date  demethylation  egfr  erlotinib  escaping  exposing  gefitinib  ie  immunoreactivity  necessarily  neoplastic  novo  overcoming  parental  pc9  pivotal  predictor  pronounced  restores  tkis  treating  tumoural 
Tagcloud (Difference) ?
acquiring  adenocarcinoma  autophagy  became  came  constitutive  date  demethylation  egfr  erlotinib  escaping  exposing  gefitinib  ie  immunoreactivity  necessarily  neoplastic  novo  overcoming  parental  pc9  pivotal  predictor  pronounced  restores  tkis  treating  tumoural 
Tagcloud (Intersection) ?